WallStSmart
GRCE

Grace Therapeutics, Inc.

NASDAQ: GRCE · HEALTHCARE · BIOTECHNOLOGY

$2.10
+0.00% today

Updated 2026-04-29

Market cap
$33.42M
P/E ratio
P/S ratio
197.75x
EPS (TTM)
$-0.31
Dividend yield
52W range
$2 – $5
Volume
0.8M

Grace Therapeutics, Inc. (GRCE) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+72.8%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+72.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.8%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+1.0%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-12$-0.14+64.4%$3.59$3.61+0.6%
2025-11-13$-0.06+82.6%$3.03$3.06+1.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.39$-0.14+64.4%
2025-09-30$-0.34$-0.06+82.6%
2025-06-30$-0.31$-0.21+31.8%
2025-03-31$-0.40$0.05+112.6%$8000.00
2024-12-31$-0.46$-0.51-11.7%
2024-09-30$-0.50$-0.42+16.8%
2024-06-30$-0.36$-0.33+9.0%
2024-03-31$-0.47$-0.36+24.1%
2023-12-31$-0.21
2023-09-30$-0.11$-0.43-290.9%
2023-06-30$-0.12$-0.54-350.0%
2023-03-31$-0.14$-0.65-364.3%

Frequently asked questions

Has Grace Therapeutics, Inc. beaten earnings estimates?
Grace Therapeutics, Inc. has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +72.8% over the last 4 quarters.
How does GRCE stock react to earnings?
GRCE stock has moved an average of +0.8% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.